Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMears Regulatory News (MER)

Share Price Information for Mears (MER)

Share Price is delayed by 15 minutes
Get Live Data
409.00    -13.00 (-3.08%)
Bid:
410.00
Ask:
411.00
Spread: 1.00 (0.244%)
Market Cap: £327.83m
MER Live PriceLast checked at - London Stock Exchange

Intraday Mears Share Chart

Rule 8.3- MEARS GROUP PLC

21 Dec 2009 14:12

RNS Number : 4878E
BlackRock Group
21 December 2009
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

BlackRock Group

Company dealt in

Mears Group PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

1p Ordinary

Date of dealing

18th December 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

1,612,861

2.17%

(2) Derivatives (other than options)

-2,573,653

-3.46%

(3) Options and agreements to purchase/sell

Total

1,612,861

2.17%

-2,573,653

-3.46%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Started late

 Class of relevant security: 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Sale

22,134

GBP 2.685333

Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Short

1,800

GBP 2.659202

CFD

Short

2,779

GBP 2.688156

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name e.g. call option 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5) 

 

 (ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

21st December 2009

Contact name

Nicola Hylton

Telephone number

020 7743 2621

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETTBBITMMBTBTL
Date   Source Headline
13th Dec 20236:07 pmRNSTransaction in Own Shares
12th Dec 20236:00 pmRNSTransaction in Own Shares
12th Dec 202310:09 amRNSHolding(s) in Company
12th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20236:09 pmRNSTransaction in Own Shares
8th Dec 202311:32 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202311:34 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20236:19 pmRNSTransaction in Own Shares
7th Nov 20235:08 pmRNSTransaction in Own Shares
7th Nov 202310:33 amRNSHolding(s) in Company
6th Nov 20235:40 pmRNSTransaction in Own Shares
3rd Nov 20235:25 pmRNSTransaction in Own Shares
2nd Nov 20236:10 pmRNSTransaction in Own Shares
2nd Nov 202312:05 pmRNSTotal Voting Rights
1st Nov 20235:05 pmRNSTransaction in Own Shares
31st Oct 20235:32 pmRNSTransaction in Own Shares
30th Oct 20236:07 pmRNSTransaction in Own Shares
27th Oct 20235:03 pmRNSTransaction in Own Shares
26th Oct 20235:35 pmRNSTransaction in Own Shares
25th Oct 20235:50 pmRNSTransaction in Own Shares
24th Oct 20235:24 pmRNSHolding(s) in Company
24th Oct 20235:17 pmRNSTransaction in Own Shares
24th Oct 20239:19 amRNSReduction of Capital Effective
23rd Oct 20235:30 pmRNSTransaction in Own Shares
20th Oct 20235:46 pmRNSTransaction in Own Shares
19th Oct 20236:11 pmRNSTransaction in Own Shares
19th Oct 20234:26 pmRNSHolding(s) in Company
18th Oct 20235:31 pmRNSTransaction in Own Shares
17th Oct 20235:11 pmRNSTransaction in Own Shares
16th Oct 20236:01 pmRNSTransaction in Own Shares
13th Oct 20235:56 pmRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
11th Oct 20235:46 pmRNSTransaction in Own Shares
11th Oct 20237:00 amRNSBlock listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.